首页> 美国卫生研究院文献>JCO Clinical Cancer Informatics >Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

【2h】

Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

机译：预期免疫抑制性癌症治疗的血液学或实体恶性肿瘤患者乙肝病毒筛查和管理的成本-效果分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

National hepatitis B virus (HBV) screening recommendations for patients with cancer anticipating systemic anticancer therapy range from universal screening to screening based on risk of HBV infection, cancer therapy–specific risk of HBV reactivation, or both. We conducted cost-effectiveness analyses to identify optimal HBV screening strategies.

机译：针对预期系统性抗癌治疗的癌症患者的国家乙型肝炎病毒（HBV）筛查建议，范围从通用筛查到基于HBV感染风险的筛查，特定于癌症治疗的HBV活化风险或两者兼而有之。我们进行了成本效益分析，以确定最佳的HBV筛查策略。

著录项

期刊名称 JCO Clinical Cancer Informatics
作者
Jessica P. Hwang; Danmeng Huang; John M. Vierling; Maria E. Suarez-Almazor; Ya-Chen Tina Shih; Mariana Chavez-MacGregor; Zhigang Duan; Sharon H. Giordano; Dawn L. Hershman; Michael J. Fisch; Scott B. Cantor;
展开▼
作者单位

展开▼
年(卷),期 -1(3),-1
年度 -1
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类生理学;
关键词

相似文献

外文文献
中文文献
专利

1. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy [J] . Man Fai Law, Carmen KM Cheung, Lydia HP Tam, World Journal of Gastroenterology . 2016,第28期

机译：抗癌疗法治疗血液系统恶性肿瘤患者乙肝病毒再激活的预防和管理
2. Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis [J] . Wong William W. L., Hicks Lisa K., Hong-Anh Tu, Breast cancer research and treatment. . 2015,第3期

机译：早期乳腺癌患者辅助化疗前的乙型肝炎病毒筛查：成本效益分析
3. Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy. [J] . Francisci D, Falcinelli F, Schiaroli Infection . 2010,第1期

机译：化疗治疗的血液恶性肿瘤患者的乙肝病毒再激活管理。
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy [O] . SHIH-HAO YOUNG, TIEN-HSIN WEI, CHUNG-CHI LIN, -1

机译：癌症化疗开始前非血液系统恶性肿瘤的慢性乙型肝炎患者基线乙型肝炎病毒DNA水平分析
7. 288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib [O] . Alexandre Malek, Yago Nieto, Ariel D Szvalb, 2019

机译：288.抗癌治疗后血液学恶性肿瘤患者的乙型肝炎病毒重新激活，包括Ibrutinib

Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

摘要

著录项

相似文献

相关主题

期刊订阅